Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Vaccines
•
Allergy & Immunology
How long do you counsel patients to wait after rituximab therapy before getting live vaccines?
Related Questions
Do mRNA vaccines lead to increased rates of acute/chronic urticaria?
Does splitting the dose of a vaccine during an observed administration affect the efficacy of the vaccine response?
Would you use the pneumococcal conjugate-21 vaccine (Capvaxive) instead of the conjugate-20 (Prevnar-20) for routine vaccinations in immunosuppressed patients?
Why are influenza and COVID vaccines still recommended for patients on immunoglobulin replacement therapy?
Do patients with a PEG allergy have a contraindication to receiving mRNA vaccines?
Do you consider immunoglobulin replacement in a patient who has rapidly waning vaccine titers but does appropriately respond to revaccination?
Do you diagnose MCAS if a patient is concurrently on drugs known to cause non-specific mast cell degranulation?
What factors do you consider prior to offering a trial of ICS/LABA therapy versus a methacholine challenge test in patients with suspected asthma but normal pulmonary function testing?
Do you continue to check tryptase levels in your patients with idiopathic anaphylaxis despite normal levels >5 on repeated checks?
When would you recommend prescribing an asthmatic patient budesonide/salbutamol rather than budesonide/formoterol?
